Vinorelbine Injection Vinelbine

Product/Composition Vinorelbine Injection
Strength 10mg/1ml, 50mg/5ml
Form Injection
Production Capacity 10 Million Vials/Month
Packaging 1 Vial / Box
Therapeutic use Non-Small Cell Lung Cancer & Breast Cancer
Package Insert/Leaflet Available upon request
Brand Name Vinelbine

Vinorelbine Injection – Vinelbine is a cytotoxic anticancer medicine containing Vinorelbine, a semi-synthetic vinca alkaloid used primarily in the treatment of certain solid tumors, particularly non-small cell lung cancer (NSCLC) and breast cancer.

Vinorelbine works by binding to tubulin and inhibiting microtubule formation. This disrupts the mitotic process and prevents cancer cells from dividing and multiplying.

Vinelbine is administered by qualified healthcare professionals under the supervision of an oncologist. The dosage and treatment schedule depend on the patient’s diagnosis, chemotherapy regimen, body surface area, blood counts, organ function, and treatment response.

What is Vinorelbine?

Vinorelbine is a vinca alkaloid antineoplastic agent that interferes with microtubule assembly during cell division. This produces an antimitotic effect and inhibits the proliferation of susceptible cancer cells.

It is commonly used as part of combination chemotherapy or as a single agent in specific oncology treatment protocols.

Benefits / Uses

Vinorelbine Injection may be used for:

  • Non-small cell lung cancer (NSCLC)
  • Advanced or metastatic breast cancer
  • Selected solid tumors according to established oncology protocols
  • Combination chemotherapy regimens with other anticancer medicines

The specific indication and treatment regimen should be determined by the treating oncologist.

Dosage Guidelines

Vinorelbine Injection is administered intravenously by qualified healthcare professionals.

  • The dose is generally calculated according to the prescribed oncology protocol and may be based on body surface area.
  • Treatment is usually given at scheduled intervals, depending on the regimen.
  • Blood counts should be monitored before and during treatment because of the risk of neutropenia.
  • Dose modification or treatment interruption may be required in patients who develop significant toxicity or have impaired liver function.
  • The injection should be administered using appropriate precautions because extravasation can cause local tissue injury.

The exact dose and administration schedule should always follow the product information and oncologist’s instructions.

Wholesale & Supply

Vinelbine – Vinorelbine Injection can be supplied for hospitals, oncology centers, pharmaceutical distributors, wholesalers, and international healthcare markets, subject to applicable regulatory requirements.

Bulk pharmaceutical buyers can request:

  • Available strengths and presentations
  • Packaging configuration
  • Minimum order quantity
  • Production and supply capacity
  • Certificate of Analysis (CoA)
  • Product documentation
  • Regulatory and export documents

Buying Online

Vinorelbine is a prescription cytotoxic chemotherapy medicine and should only be procured through authorized pharmaceutical suppliers and used under qualified medical supervision.

Hospitals, licensed distributors, and healthcare procurement organizations can contact the supplier for product availability, commercial quotations, and applicable documentation.

Reviews

Individual responses to Vinorelbine-based chemotherapy vary according to cancer type, disease stage, treatment regimen, and patient characteristics. Treatment decisions should therefore be based on professional oncology assessment rather than individual product reviews.

Quality Assurance

Vinelbine should be manufactured and handled according to applicable pharmaceutical quality requirements. Quality-control testing for injectable products may include:

  • Identity and assay
  • Sterility
  • Purity and related substances
  • Appearance
  • Particulate matter
  • Container-closure integrity
  • Stability testing
  • Appropriate storage conditions

Product-specific quality and regulatory documentation can be provided upon request, where applicable.

Frequently Asked Questions

What is Vinelbine used for?

Vinelbine contains Vinorelbine and is used primarily in the treatment of non-small cell lung cancer and advanced or metastatic breast cancer according to appropriate oncology protocols.

What type of medicine is Vinorelbine?

Vinorelbine is a semi-synthetic vinca alkaloid and cytotoxic antineoplastic medicine that inhibits microtubule formation during cell division.

How is Vinelbine Injection administered?

Vinelbine is administered intravenously by qualified healthcare professionals. Appropriate precautions are required during administration to minimize the risk of extravasation.

Is Vinorelbine used alone or with other medicines?

Vinorelbine may be used either as a single agent or in combination with other anticancer medicines, depending on the cancer type and treatment protocol.

What are the important side effects of Vinorelbine?

Common or clinically important adverse effects may include neutropenia, anemia, nausea, constipation, fatigue, peripheral neuropathy, and injection-site reactions. Blood counts and other relevant parameters require monitoring.

Does Vinelbine require specialist supervision?

Yes. Vinorelbine is a cytotoxic chemotherapy medicine and should be prescribed, prepared, administered, and monitored by appropriately trained healthcare professionals.

Conclusion

Vinelbine – Vinorelbine Injection is a vinca alkaloid anticancer medicine used in established chemotherapy protocols, particularly for non-small cell lung cancer and advanced breast cancer. Its use requires appropriate patient selection, blood-count monitoring, and professional administration to manage potential hematological and other toxicities.